Search clinical trials for: recombinant

Total 3395 results

Amgen

Completed

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy

Genital Neoplasms, Female | Anemia | Gynecological Malignancies
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Hemophilia B
University of Calgary
Ortho Biotech, Inc.; Calgary Health Region

Completed

The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)

Brain Injury | Cardiac Surgery

Canada
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Virus Diseases | Influenza

United States
University of Texas Southwestern Medical Center
Scios, Inc.

Completed

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Heart Failure, Congestive | Cardiomyopathy

United States
InterMune

Completed

An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Pulmonary Fibrosis | Lung Disease

United States
FibroGen

Completed

A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

Renal Anemia

United States
Rigshospitalet, Denmark
Odense University Hospital; Karolinska University Hospital; Hvidovre University... and other collaborators

Completed

Nordic Luveris Study

Infertility | In Vitro Fertilization

Denmark
Federico II University

Completed

Effect of 5 Years of GH Replacement on Atherosclerosis (5yrGH)

Growth Hormone Deficiency | Hypopituitarism | Pituitary Tumors

Italy
Recoly N.V.

Completed

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

Haemophilia A

Russian Federation
Octagen Corporation
Biomeasure Inc, Ipsen Group

Completed

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Hemophilia A

United States
French National Agency for Research on AIDS and...
Hoffmann-La Roche; InterMune

Completed

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

Hepatitis C, Chronic

France
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

HIV Infections

Australia
Kaken Pharmaceutical

Completed

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

Periodontitis
University of Bologna
Novartis; Schering-Plough

Terminated

Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)

Chronic Myeloid Leukemia
University of Milan
Eli Lilly and Company

Unknown

Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)

Growth Hormone Deficiency, Dwarfism | Pseudohypoparathyroidism

Italy
Centro Medico Teknon

Completed

Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)

Fibromyalgia | Growth Hormone Deficiency

Spain
University Hospital, Lille
Organon

Completed

Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome (SOPK)

Anovulation

France
Assistance Publique - Hôpitaux de Paris

Unknown

Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease (HEART)

Fabry Disease

France
Medical University of Vienna

Completed

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

Hemophilia A

Austria
Hamamatsu University

Completed

Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis

Hemodialysis
Hamamatsu University
Maruyama Memorial General Hospital; Seirei Hamamatsu General Hospital; Iwata... and other collaborators

Terminated

Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning HD

Renal Dialysis
Insmed Incorporated

Terminated

Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome

Noonan Syndrome

United States
Hadassah Medical Organization

Unknown

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Tumors

Israel
Baxter Healthcare Corporation

Completed

A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin

Healthy

Germany
Oncology Institute of Southern Switzerland

Completed

OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation

Differentiated Thyroid Carcinoma
NHS Greater Glasgow and Clyde

Completed

Efficacy and Safety of R-hLH (Luveris ®) Priming Prior to R-HFSH Treatment in Infertile Women Undergoing IVF-ET

Infertility

Denmark, France, United Kingdom
Kirby Institute
The University of New South Wales; Virax Pty. Ltd,

Completed

ITV Extension Study

HIV

Australia
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Tuberculosis

United Kingdom
QDose Limited

Unknown

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

Diabetes Mellitus

United States
BZL Biologics

Completed

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Prostatic Neoplasms

United States
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Tuberculosis

United Kingdom
Global Biotech

Completed

Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Cerebrovascular Accident

Taiwan
Stallergenes Greer

Terminated

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Allergy

France
Altus Pharmaceuticals

Completed

Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

Adult Growth Hormone Deficiency

United States
Corixa Corporation

Unknown

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
University of Aarhus

Completed

Clot Formation and Clot Stability in Patients With Severe Haemophilia A

Hemophilia A

Denmark
BioMarin Pharmaceutical

Completed

Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI

Mucopolysaccharidosis VI

United States
University Of Perugia

Unknown

rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets

Intracerebral Hemorrhage

Italy
Johns Hopkins University
Ventria Bioscience

Unknown

Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.

Clostridium Difficile

United States
Yale University
American Heart Association

Completed

Effects of Recombinant Human Erythropoietin on Platelet Function in Healthy Subjects

Healthy Subjects

United States
Stanford University

Completed

Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults

Obesity | Metabolic Syndrome | Impaired Glucose Tolerance

United States
Halozyme Therapeutics

Completed

A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects

Healthy

United States
Hamamatsu University
Maruyama Memorial General Hospital; Seirei Hamamatsu General Hospital; Iwata... and other collaborators

Completed

Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)

Renal Dialysis
Chiron Corporation

Completed

Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments

Lymphoma, Non-Hodgkin

United States
Chiron Corporation

Completed

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Lymphoma, Non-Hodgkin

United States
Genesys
Novo Nordisk A/S

Completed

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Sepsis | Respiratory Failure | Renal Failure | Surgical Site Infection

United States
University of Aarhus

Completed

Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?

Vitamin B12 Deficiency

Denmark
The University of Hong Kong

Completed

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Hepatocellular Carcinoma

3

Subscribe